Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at saracatinib for pain caused by cancer spread to the bone (SarCaBon)

Overview

Cancer types:

Cancer spread to the bone, Secondary cancers

Status:

Results

Phase:

Phase 2

Details

This trial was to see if a drug called saracatinib could reduce the pain that cancer spread to the bones can cause.

This trial was open for people to join between 2014 and 2017, and the team published the results in 2019.

Recruitment start: 13 March 2014

Recruitment end: 19 June 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr David Andrew

Supported by

AstraZeneca

Experimental Cancer Medicine Centre (ECMC)

Medical Research Council (MRC)

NIHR Clinical Research Network: Cancer

Sheffield Teaching Hospitals NHS Foundation Trust

University of Sheffield

Last reviewed: 24 March 2021

CRUK internal database number: 11770

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.